Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Real World Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide(BIC/FTC/TAF) in PLWH in Precarity Settings in France

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07122557
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:27.228098+00:00
Published At
2025-08-14T00:00:00+00:00
Record Updated At
2025-08-14
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["HIV-1", "Public Universal Healthcare Insurance Coverage", "BIC/FTC/TAF", "Low Income Population"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-08-14"
protocolSection.identificationModule.nctId
"NCT07122557"
protocolSection.identificationModule.officialTitle
"Real World Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide(BIC/FTC/TAF) in PLWH in Precarity Settings in France"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • HIV-1 (protocolSection.conditionsModule.conditions)
  • Public Universal Healthcare Insurance Coverage (protocolSection.conditionsModule.conditions)
  • BIC/FTC/TAF (protocolSection.conditionsModule.conditions)
  • Low Income Population (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.